FollowTheFilings
Managers
Activity
Compare
Newest
Investment
WHITEHAWK THERAPEUTICS INC
Historical 13F holders
CUSIP
00032Q104
Type
Equity
Class
COM
Period
13F filings
2026 Q1
4
2025 Q4
4
2025 Q3
3
2025 Q2
3
2025 Q1
7
2024 Q4
7
2024 Q3
6